Understanding inflammatory bowel disease via immunogenetics

Journal of Autoimmunity

Volumn 64, Issue , 2015, Pages 91-100

  de Lange, Katrina M ^a   Barrett, Jeffrey C ^a,b,c  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Italy)

^c Centre for Therapeutic Target Validation   (United Kingdom)

Author keywords

Genetics; Genome wide association study; Inflammatory bowel disease; Microbial sensing; Therapeutic targets

Indexed keywords

STAT PROTEIN;

ALLELE; AUTOPHAGY; CELL DIFFERENTIATION; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GENE ACTIVATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; LEPROSY; LOSS OF FUNCTION MUTATION; META ANALYSIS (TOPIC); NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ULCERATIVE COLITIS; ADAPTIVE IMMUNITY; ANIMAL; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASES; RISK FACTOR;

ADAPTIVE IMMUNITY; ANIMALS; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNITY, INNATE; IMMUNOGENETICS; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASES; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84946478514     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.07.013     Document Type: Review

References (102)

1. Baumgart D., Sandborn W. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet May 2007, 369:1641-1657. Available at:. http://www.sciencedirect.com/science/article/pii/S014067360760751X.
2. Bernstein C.N., Fried M., Krabshuis J.H., et al. World gastroenterology organization practice guidelines for the diagnosis and management of IBD in 2010. Inflamm. Bowel Dis. 2010, 16(1):112-124. 10.1002/ibd.21048.
3. Molodecky N.A., Soon I.S., Rabi D.M., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142(1):46-54. 10.1053/j.gastro.2011.10.001.
4. Sands B.E., Grabert S. Epidemiology of inflammatory bowel disease and overview of pathogenesis. Med. Health Rhode Isl. 2009, 92(3):73-77.
5. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126(6):1504-1517. 10.1053/j.gastro.2004.01.063.
6. M'Koma A.E. Inflammatory bowel disease: an expanding global health problem. Clin. Med. Insights Gastroenterol. 2013, 6:33-47. 10.4137/CGast.S12731.
7. Halme L., Paavola-Sakki P., Turunen U., Lappalainen M., Farkkila M., Kontula K. Family and twin studies in inflammatory bowel disease. World J. Gastroenterol. 2006, 12(23):3668-3672. Available at:. http://office.wjgnet.com/1007-9327/full/v12/i23/3668.htm.
8. Brant S.R. Update on the heritability of inflammatory bowel disease: the importance of twin studies. Inflamm. Bowel Dis. 2011, 17(1):1-5. 10.1002/ibd.21385.
9. Liu J.Z., Anderson C.A. Genetic studies of Crohn's disease: past, present and future. Best. Pract. Res. Clin. Gastroenterol. 2014, 28(3):373-386. 10.1016/j.bpg.2014.04.009.
10. Gusella J.F., Wexler N.S., Conneally P.M., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983, 306(17):234-238. 10.1038/306234a0.
11. Tsui L.-C., Buchwald M., Barker D., et al. Cystic fibrosis locus defined by a genetically linked polymorphic marker. Science 1985, 230:1054-1057. (80).
12. Seizinger B.R., Rouleau G.A., Ozelius L.J., et al. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 1987, 49(5):589-594. Available at:. http://www.sciencedirect.com/science/article/pii/0092867487905344.
13. Vance J.M., Nicholson G a, Yamaoka L.H., et al. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp. Neurol. 1989, 104(2):186-189. 10.1016/S0014-4886(89)80013-5.
14. Siddique T., Figlewicz D.A., Pericak-Vance M.A., et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N. Engl. J. Med. 1991, 324(20):1381-1384. 10.1056/NEJM199105163242001.
15. Kandt R.S., Haines J.L., Smith M., et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat. Genet. 1992, 2(1):37-41. 10.1038/ng0992-37.
16. Speer M.C., Yamaoka L.H., Gilchrist J.H., et al. Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q. Am. J. Hum. Genet. 1992, 50(6):1211-1217.
17. Hugot J.-P., Laurent-Puig P., Gower-Rousseau C., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996, 379. Available at:. http://www.nature.com/nature/journal/v379/n6568/abs/379821a0.html.
18. Ohmen J.D., Yang H., Yamamoto K.K., et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum. Mol. Genet. 1996, 5(10):1679-1683.
19. Parkes M., Satsangi J., Lathrop G.M., Bell J.I., Jewell D.P. Susceptibility loci in inflammatory bowel disease. Lancet 1996, 348(9041):1588. 10.1016/S0140-6736(05)66204-6.
20. Curran M.E., Lau K.I.T.F., Hampe J., et al. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology 1998, 115:1066-1071.
21. Brant S.R., Fu Y., Fields C.T., et al. American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology 1998, 115:1056-1061. Available at:. http://www.sciencedirect.com/science/article/pii/S0016508598700733.
22. Cavanaugh J.A., Callen D.F., Wilson S.R., et al. Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. Ann. Hum. Genet. 1998, 62(Pt 4):291-298. 10.1046/j.1469-1809.1998.6240291.x.
23. Cavanaugh J. The international IBD genetics consortium. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am. J. Hum. Genet. 2001, 68:1165-1171.
24. Hugot J.-P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature May 2001, 411:599-603. Available at:. http://www.nature.com/nature/journal/v411/n6837/abs/411599a0.html.
25. Ogura Y., Bonen D., Inohara N., Nicolae D. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature May 2001, 411:603-606. Available at:. http://www.nature.com/nature/journal/v411/n6837/abs/411603a0.html.
26. Philpott D.J., Sorbara M.T., Robertson S.J., Croitoru K. NOD proteins: regulators of inflammation in health and disease. Nat. Rev. Immunol. 2014, 14:9-23. 10.1038/nri3565.
27. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517. (80).
28. Ioannidis J.P.A. Genetic associations: false or true?. Trends Mol. Med. 2003, 9(4):135-138. 10.1016/S1471-4914(03)00030-3.
29. Sachidanandam R., Weissman D., Schmidt S.C., et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001, 409(6822):928-933. 10.1038/35057149.
30. A haplotype map of the human genome. Nature 2005, 437(7063):1299-1320. The International HapMap Consortium. 10.1038/nature04226.
31. Mcvean G.A.T., Myers S.R., Hunt S., Deloukas P., Bentley D.R., Donnelly P. The fine-scale structure of recombination rate variation in the human genome. Science 2004, 304:581-584. (80).
32. Barrett J.C., Cardon L.R. Evaluating coverage of genome-wide association studies. Nat. Genet. 2006, 38(6):659-662. 10.1038/ng1801.
33. Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314(5804):1461-1463. (80). 10.1126/science.1135245.
34. Hampe J., Franke A., Rosenstiel P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 2007, 39(2):207-211. 10.1038/ng1954.
35. Libioulle C., Louis E., Hansoul S., et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 2007, 3(4):538-543. 10.1371/journal.pgen.0030058.
36. Rioux J.D., Xavier R.J., Taylor K.D., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 2007, 39(5):596-604. 10.1038/ng2032.
37. Van Limbergen J., Wilson D.C., Satsangi J. The genetics of Crohn's disease. Annu. Rev. Genomics Hum. Genet. 2009, 10:89-116. 10.1146/annurev-genom-082908-150013.
38. Fisher S.A., Tremelling M., Anderson C.A., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat. Genet. 2008, 40(6):710-712. 10.1038/ng.145.
39. Franke A., Balschun T., Karlsen T.H., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 2008, 40(11):1319-1323. 10.1038/ng.221.
40. Silverberg M.S., Cho J.H., Rioux J.D., et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat. Genet. 2009, 41(2):216-220. 10.1038/ng0609-762a.
41. Barrett J.C., Lee J.C., Lees C.W., et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat. Genet. 2009, 41(12):1330-1334. 10.1038/ng.483.
42. Satsangi J., Welsh K.I., Bunce M., et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996, 347:1212-1217. Available at:. http://www.sciencedirect.com/science/article/pii/S0140673696907345.
43. Zhernakova A., van Diemen C.C., Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 2009, 10(1):43-55. 10.1038/nrg2489.
44. Goyette P., Boucher G., Mallon D., et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat. Genet. 2015, 47(2):172-179. 10.1038/ng.3176.
45. Nejentsev S., Howson J.M.M., Walker N.M., et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007, 450(7171):887-892. 10.1038/nature06406.
46. Maher B. The case of the missing heritability. Nat. News Featur. 2008, 456:18-21. 10.1038/456018a.
47. Manolio T.A., Collins F.S., Cox N.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753. 10.1038/nature08494.
48. Abecasis G.R., Altshuler D., Auton A., et al. A map of human genome variation from population-scale sequencing. Nature 2010, 467(7319):1061-1073. 10.1038/nature09534.
49. Barrett J.C., Hansoul S., Nicolae D.L., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 2008, 40(8):955-962. 10.1038/ng.175.
50. Anderson C.A., Boucher G., Lees C.W., et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 2011, 43(3):246-252. 10.1038/ng.764.
51. Franke A., McGovern D.P.B., Barrett J.C., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 2010, 42(12):1118-1125. 10.1038/ng.717.
52. Jostins L., Ripke S., Weersma R.K., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491(7422):119-124. 10.1038/nature11582.
53. Parkes M., Cortes A., van Heel D.A., Brown M.A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 2013, 14(9):661-673. 10.1038/nrg3502.
54. Yamazaki K., McGovern D., Ragoussis J., et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 2005, 14(22):3499-3506. 10.1093/hmg/ddi379.
55. Yamazaki K., Takazoe M., Tanaka T., Kazumori T., Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J. Hum. Genet. 2002, 47:469-472.
56. Yamazaki K., Takazoe M., Tanaka T., et al. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J. Hum. Genet. 2004, 49:664-668. 10.1007/s10038-004-0204-x.
57. Negoro K., McGovern D.P.B., Kinouchi Y., et al. Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut 2003, 52:541-546.
58. Asano K., Matsushita T., Umeno J., et al. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat. Genet. 2009, 41(12):1325-1329. 10.1038/ng.482.
59. Juyal G., Negi S., Sood A., et al. Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis. Gut 2015, 64:571-579. 10.1136/gutjnl-2013-306625.
60. Yamazaki K., Umeno J., Takahashi A., et al. A genome-wide association study identifies 2 susceptibility loci for Crohn's disease in a Japanese population. Gastroenterology 2013, 144:781-788. 10.1053/j.gastro.2012.12.021.
61. Yang S.-K., Hong M., Zhao W., et al. Genome-wide association study of ulcerative colitis in Koreans suggests extensive overlapping of genetic susceptibility with Caucasians. Inflamm. Bowel Dis. 2013, 19(5):954-966. 10.1097/MIB.0b013e3182802ab6.
62. Yang S., Hong M., Zhao W., et al. Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut 2014, 63:80-87. 10.1136/gutjnl-2013-305193.
63. Liu J.Z., van Sommeren S., Huang H., et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 2015, Advanced online publication. 10.1038/ng.3359.
64. Shih D.Q., Kwan L.Y., Chavez V., et al. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur. J. Immunol. 2009, 39(11):3239-3250. 10.1002/eji.200839087.Microbial.
65. Chen G.-B., Lee S.H., Brion M.-J.A., et al. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data. Hum. Mol. Genet. 2014, 23(17):4710-4720.
66. Chang D., Gao F., Slavney A., et al. Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases. PLoS One 2014, 9(12):e113684. 10.1371/journal.pone.0113684.
67. Uhlig H.H. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut 2013, 62(12):1795-1805. 10.1136/gutjnl-2012-303956.
68. Zeissig Y., Petersen B.-S., Milutinovic S., et al. XIAP variants in male Crohn's disease. Gut 2014, 1-11. 10.1136/gutjnl-2013-306520.
69. Li B., Liu D.J., Leal S.M. Identifying rare variants associated with complex traits via sequencing. Curr. Protoc. Hum. Genet. 2013, 1.26.1-1.26.22. 10.1002/0471142905.hg0126s78.
70. Glocker E., Kotlarz D., Boztug K., et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 2009, 361(21):2033-2045. 10.1056/NEJMoa0907206.Inflammatory.
71. Blaydon D., Biancheri P., Di W., et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N. Engl. J. Med. 2011, 365:1502-1508. 10.1056/NEJMoa1100721.
72. Rivas M.A., Beaudoin M., Gardet A., et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet. 2011, 43(11):1066-1073.
73. Beaudoin M., Goyette P., Boucher G., et al. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet. 2013, 9(9). 10.1371/journal.pgen.1003723.
74. Zuk O., Schaffner S.F., Samocha K., et al. Searching for missing heritability: designing rare variant association studies. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E455-E464. 10.1073/pnas.1322563111.
75. Ng S.B., Turner E.H., Robertson P.D., et al. Targeted capture and massively parallel sequencing of twelve human exomes. Nature 2009, 461(7261):272-276. 10.1038/nature08250.Targeted.
76. Li Y., Sidore C., Kang H.M., Boehnke M., Abecasis G.R. Low-coverage sequencing: implications for design of complex trait association studies. Genome Res. 2011, 21:940-951. 10.1101/gr.117259.110.individuals.
77. Trynka G., Hunt K.A., Bockett N.A., et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 2011, 43(12):1193-1201. 10.1038/ng.998.
78. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489(7414):57-74. The ENCODE Project Consortium. 10.1038/nature11247.An.
79. Farh K.K.-H., Marson A., Zhu J., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015, 518:337-343. 10.1038/nature13835.
80. Kichaev G., Yang W., Lindstrom S., et al. Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet. 2014, 10(10). 10.1371/journal.pgen.1004722.
81. Monteleone G., Neurath M.F., Ardizzone S., et al. Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. N. Engl. J. Med. 2015, 372(12):1104-1113. 10.1056/NEJMoa1407250.
82. James D.G., Seo D.H., Chen J., Vemulapalli C., Stone C.D. Efalizumab, a human monoclonal anti-CD11a antibody, in the treatment of moderate to severe Crohn's disease: an open-label pilot study. Dig. Dis. Sci. 2011, 56(6):1806-1810. 10.1007/s10620-010-1525-6.
83. Silverberg M.S., Mirea L., Bull S.B., et al. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease. Inflamm. Bowel Dis. 2003, 9(1):1-9. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/12656131.
84. Cleynen I., González J.R., Figueroa C., et al. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European project. Gut 2013, 62(11):1556-1565. 10.1136/gutjnl-2011-300777.
85. Haritunians T., Taylor K.D., Targan S.R., et al. Genetic predictors of medically refractory ulcerative colitis. Inflamm. Bowel Dis. 2010, 16(11):1830-1840. 10.1002/ibd.21293.Genetic.
86. Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474:308-317. 10.1038/nature10209.
87. Kostic A.D., Xavier R.J., Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014, 146(6):1489-1499. 10.1053/j.gastro.2014.02.009.
88. Dethlefsen L., Huse S., Sogin M.L., Relman D a The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16s rRNA sequencing. PLoS Biol. 2008, 6(11):2383-2400. 10.1371/journal.pbio.0060280.
89. Antonopoulos D.A., Huse S.M., Morrison H.G., Schmidt T.M., Sogin M.L., Young V.B. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 2009, 77(6):2367-2375. 10.1128/IAI.01520-08.
90. Schloss P.D., Iverson K.D., Petrosino J.F., Schloss S.J. The dynamics of a family's gut microbiota reveal variations on a theme. Microbiome 2014, 2(1):25. 10.1186/2049-2618-2-25.
91. Eiseman B., Silen W., Bascom G.S., Kauvar A.J. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958, 44(5):854-859. 10.1067/S0039-6060(03)00474-4.
92. Suskind D.L., Brittnacher M.J., Wahbeh G., et al. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflamm. Bowel Dis. 2015, 21(3):556-563. 10.1097/MIB.0000000000000307.
93. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678. The Wellcome Trust Case Control Consortium. 10.1038/nature05911.
94. Brown E.M., Sadarangani M., Finlay B.B. The role of the immune system in governing host-microbe interactions in the intestine. Nat. Immunol. 2013, 14(7):660-667. 10.1038/ni.2611.
95. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 2013, 45(7):730-738. International Genetics of Ankylosing Spondylitis Consortium. 10.1038/ng.2667.
96. Tsoi L.C., Spain S.L., Ellinghaus E., et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nat. Commun. May 2015, 1-8. 10.1038/ncomms8001.
97. Onengut-Gumuscu S., Chen W., Burren O., et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 2015, 47(4):381-386. 10.1038/ng.3245.
98. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 2013, 45(11):1353-1360. International Multiple Sclerosis Genetics Consortium. 10.1038/ng.2770.
99. Festen E.A.M., Goyette P., Green T., et al. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease. PLoS Genet. 2011, 7(1):3-8. 10.1371/journal.pgen.1001283.
100. Okada Y., Wu D., Trynka G., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014, 506(7488):376-381. 10.1038/nature12873.
101. Han J.-W., Zheng H.-F., Cui Y., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 2009, 41(11):1234-1237. 10.1038/ng.472.
102. Weaver C.T., Hatton R.D. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat. Rev. Immunol. 2009, 9(12):883-889. 10.1038/nri2660.